Aicardi Goutières Syndrome
6 clinical trials · Condition
◉ Watch Aicardi Goutières Syndrome
| Record | Firm | Date |
|---|---|---|
| Reverse Transcriptase Inhibitors in Aicardi Goutières Syndrome (NCT03304717) | Children's Hospital of Philadelphia | 2025-12-01 |
| Inhibition of Reverse Transcription in Aicardi-Goutières Syndrome (NCT04731103) | University of Edinburgh | 2022-08-24 |
| A Study of Baricitinib (LY3009104) in Adult and Pediatric Japanese Participants With NNS/CANDLE, SAVI, and AGS (NCT04517253) | Eli Lilly and Company | 2020-10-27 |
| JAK Inhibitor Treatment in AGS (NCT03921554) | Adeline Vanderver, MD | 2019-06-03 |
| LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies (NCT02699190) | Children's Hospital of Philadelphia | 2017-01-06 |
| The Myelin Disorders Biorepository Project (NCT03047369) | Children's Hospital of Philadelphia | 2016-12-08 |
Track Aicardi Goutières Syndrome automatically
Every clearance here is in the API, with alerts when new ones post.